[HTML][HTML] Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Y Liang, H Tang, J Guo, X Qiu, Z Yang, Z Ren… - Nature …, 2018 - nature.com
Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the
presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might …

[HTML][HTML] Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Y Liang, H Tang, J Guo, X Qiu, Z Yang… - Nature …, 2018 - ncbi.nlm.nih.gov
Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the
presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might …

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Y Liang, H Tang, J Guo, X Qiu, Z Yang… - Nature …, 2018 - pubmed.ncbi.nlm.nih.gov
Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the
presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might …

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Y Liang, H Tang, J Guo, X Qiu… - Nature …, 2018 - utsouthwestern.elsevierpure.com
Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the
presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might …

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Y Liang, H Tang, J Guo, X Qiu, Z Yang… - Nature …, 2018 - ui.adsabs.harvard.edu
Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the
presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might …

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Y Liang, H Tang, J Guo, X Qiu… - Nature …, 2018 - mayoclinic.elsevierpure.com
Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the
presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might …

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Y Liang, H Tang, J Guo, X Qiu, Z Yang… - Nature …, 2018 - search.ebscohost.com
Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the
presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might …

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Y Liang, H Tang, J Guo, X Qiu, Z Yang… - Nature …, 2018 - econpapers.repec.org
Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the
presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might …

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Y Liang, H Tang, J Guo, X Qiu, Z Yang, Z Ren… - Nature …, 2018 - europepmc.org
Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the
presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might …

[引用][C] Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Y Liang, H Tang, J Guo, X Qiu, Z Yang, Z Ren… - Nature …, 2018 - cir.nii.ac.jp
Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to
overcome checkpoint blockade resistance | CiNii Research CiNii 国立情報学研究所 学術情報 …